FDA revokes emergency use of malaria drugs for COVID-19

The U.S. Food and Drug Administration on Monday revoked its emergency use authorization for hydroxychloroquine to treat COVID-19, the drug championed by U.S. President Donald Trump to stave off the coronavirus. This report produced by Jillian Kitchener.